Table 1.

Characteristics of cases and controls

	Cases (N=208,002)	Controls (N=815,576)	Crude OR
Age (yr, SD)	60.5 (16.0)	60.2 (16.0)	NA
Sex (% Male, N)	53.3% (110,831)	53.3% (434,574)	NA
Follow-up duration (yr, SD)	5.5 (3.9)	5.5 (3.9)	NA
Obesity (BMI>30) (%, N)	40.6% (84,415)	15.1% (123,300)	4.49 (4.44–4.55)
Ever smoking (%, N)	46.6% (96,977)	36.4% (296,843)	1.65 (1.63–1.67)
Coronary artery disease (%, N)	13.3% (27,694)	7.0% (56,895)	2.18 (2.14–2.21)
Hyperlipidemia Rx Statins (%, N)	22.1% (45,905)	13.5% (109,683)	2.1 (2.07–2.13)
Urinary tract infection (%, N)	19.3% (40,051)	15.1% (123,329)	1.05 (1.04–1.05)
Skin infection (%, N)	17.8% (37,082)	12.4% (101,027)	1.11 (1.11–1.12)
Pneumonia (%, N)	3.8% (7,954)	2.7% (21,727)	1.28 (1.26–1.31)
Upper respiratory tract infection(%, N)	16.9% (35,225)	14.1% (114,990)	1.11 (1.1–1.11)
Last glucose before or at diagnosis date (mmol/L, SD)	9.1 (3.8)	5.3 (1.0)	2.76 (2.73–2.79)